Le Lézard
Classified in: Health, Science and technology, Business
Subjects: ACC, VEN

Healthware Raises ?10 Million Round Led by FII Tech Growth Fund to Boost Digital Health & DTx Operations


MILAN and SALERNO, Italy, Feb. 4, 2019 /PRNewswire/ -- Healthware and FII Tech Growth will invest more than ?10 million over the next two years to strengthen Healthware's innovative offering, aimed at improving health outcomes through new technologies.

Healthware raises ?10 million round led by FII Tech Growth Fund to boost Digital Health & DTx operations.

Healthware is a next-generation integrated consulting group that has been supporting marketing and sales in life sciences through its full-service agency for more than 20 years. It operates at the intersection of the transformation of commercial operations and digital health, offering a unique range of services combining design, strategy, communication and innovation with technology and corporate venturing.

The capital increase will reinforce Healthware's vertical focusing on business transformation for life sciences companies and product development and services for digital health start-ups.

Focus areas will include digital health platforms, digital therapeutics, health insurance and AI applications.

Healthware and its US-based joint venture partner Intouch Group, represent one of the largest global independent consultancies with a combined team of more than 1,000 dedicated specialists and offices in New York, Boston, Kansas City, Chicago, London, Cologne, Milan, Rome, Salerno and Mumbai.

Roberto Ascione, CEO & Founder of Healthware Group, says: "The health sector has begun a radical digital transformation, perhaps greater than in any other industry. Over the last 20 years Healthware has evolved into a partner able to guide this transformation of life sciences, health tech and health insurance companies, as well as the start-ups that are re-imagining these industries. The partnership with FII Tech Growth will allow us to enhance our ability to work with big companies and start-ups to accelerate their processes and the development of innovative ideas and products."

Mauro Pretolani, Senior Partner of Fondo Italiano d'Investimento SGR, who will join the Board of Healthware Group, declared: "Healthware has the potential to become a global leader in digital health innovation and will play a strategic role in both the Italian and the European healthcare industry. Fondo Italiano d'Investimento is actively committed to Healthware's development, offering both financial and operational support, in accordance with the investment strategy of FII Tech Growth fund."

Contacts:

Antonietta Pannella
Healthware Group
Mobile: +39-349-0648276
[email protected]

Roberto Del Giudice
Fondo Italiano d'Investimento SGR
Phone: +39-02-63532-1
[email protected]

 

Roberto Ascione, CEO & Founder of Healthware Group

SOURCE Healthware Group


These press releases may also interest you

at 20:16
Evolution Equity Partners announced the final closing of Evolution Technology Fund III, LP on April 16th, 2024, and total capital commitments of $ 1.1 Billion to back visionary entrepreneurs building next generation...

at 20:05
Renesas Electronics Corporation (TSE:6723) today announced consolidated financial results in accordance with IFRS for the three months ended March 31, 2024. Summary of Consolidated Financial Results (Note 1) Summary of Consolidated Financial...

at 20:00
Pulse Seismic Inc. ("Pulse" or the "Company") is pleased to report its financial and operating results for the three months ended March 31, 2024. The unaudited condensed consolidated interim financial statements, accompanying notes and MD&A are...

at 19:59
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

at 19:58
Bancorp, Inc. (the "Company") , the holding company of Needham Bank, today announced its first quarter 2024 financial results. SELECTED FINANCIAL HIGHLIGHTS FOR THE FIRST QUARTER OF 2024 Net income of $8.7 million, or $0.22 per diluted share,...

at 19:50
Newport Exploration Ltd ("Newport" or "the Company") provides an update for licences in the Cooper Basin, Australia, over which the Company has a 2.5% gross overriding royalty ("GOR"). This information was reported by Beach Energy Ltd ("Beach") in...



News published on and distributed by: